MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Studies have shown that the expression of CD133, leucine-rich-repeat-containing G-protein-coupled receptor 5 (Lgr5), and ATP binding cassette (ABC)G2 proteins is associated with malignancy and poor prognosis in colon cancer. However, molecular regulation mechanism of the three proteins has not been elucidated. Here, we report that microRNA-142-3p (miR-142-3p) inhibits the expression of CD133, Lgr5, and ABCG2 in colon cancer cells by binding to both the 3'-untranslated region and the coding sequences of the three genes. The miR-142-3p was markedly decreased in colon cancer specimens, in which it was negatively correlated with the expression of CD133, Lgr5, and ABCG2. Reduction of miR-142-3p corresponds to poor differentiation and bigger tumor size in colon cancers. Moreover, miR-142-3p levels were reduced in cells that formed spheres compared to cells that were cultured in regular media. Transfection of miR-142-3p mimics in colon cancer cells downregulated cyclin D1 expression, induced G1 phase cell cycle arrest, and elevated the sensitivity of the cells to 5-fluorouracil. Furthermore, OCT4 suppressed miR-142-3p, and hypomethylation of the OCT4 promoter was associated with a reduction in miR-142-3p. Finally, the miR-142-3p inhibited the growth of colon cancer cells in vivo, which was accompanied by the downregulation of CD133, Lgr5, and ABCG2 in tumor tissues. Our results elucidate a novel regulation pathway in colon cancer cells and suggest a potential therapeutic approach for colon cancer therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, several studies have demonstrated that using miRNA mimics to increase the levels of specific miRNAs, such as miR-133b, miR-142-3p, miR-297, and miR-522, can increase the chemosensitivity of drug-resistant CRC cells [104,105,106,107].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [105]
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Identification of stem cells in small intestine and colon by marker gene Lgr5
Barker, N., van Es, J. H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P. J., et al. (2007) · Nature · doi:10.1038/nature06196 · Cited by 5,687
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Identification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280
let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.054 · Cited by 1,910
Cummins, J. M., He, Y., Leary, R. J., Pagliarini, R., Diaz, L. A., Sjoblom, T., Barad, O., Bentwich, Z., Szafranska, A. E., Labourier, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511155103 · Cited by 744
The intestinal epithelial stem cell
Marshman, E., Booth, C., & Potten, C. S. (2002) · BioEssays · doi:10.1002/bies.10028 · Cited by 586
Zhou, S., Morris, J. J., Barnes, Y., Lan, L., Schuetz, J. D., & Sorrentino, B. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192276999 · Cited by 502
ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapy
Ding, X.-W., Wu, J.-H., & Jiang, C.-P. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.02.012 · Cited by 323
Cited by
Health benefits of resveratrol: Evidence from clinical studies
Singh, A. P., Singh, R., Verma, S. S., Rai, V., Kaschula, C. H., Maiti, P., & Gupta, S. C. (2019) · Medicinal Research Reviews · doi:10.1002/med.21565 · Cited by 523
EGBMMDA: Extreme Gradient Boosting Machine for MiRNA-Disease Association prediction
Chen, X., Huang, L., Xie, D., & Zhao, Q. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0003-x · Cited by 275
LRSSLMDA: Laplacian Regularized Sparse Subspace Learning for MiRNA-Disease Association prediction
Chen, X., & Huang, L. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005912 · Cited by 228
Diagnostic Value of Cell-free Circulating Micrornas for Obesity and Type 2 Diabetes: A Meta-analysis
Villard, A., Marchand, L., Thivolet, C., & Rome, S. (2015) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.1000251 · Cited by 142
Talib, W. H., Alsalahat, I., Daoud, S., Abutayeh, R. F., & Mahmod, A. I. (2020) · Molecules · doi:10.3390/molecules25225319 · Cited by 141
Metadata
- Authors
- Shen, W.-W., Zeng, Z., Zhu, W.-X., & Fu, G.-H.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Fu, Guo-Hui
- ORCID
- Venue
- Journal of Molecular Medicine
- Published
- 2013-04-26
- Volume
- 91
- Issue
- 8
- Pages
- 989-1000
- ISSN
- 0946-2716 (ISSN-L)
- 1432-1440
- OpenAlex
- W2017927877
- Cited by
- 137
- References
- 33
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 18 · 2020: 8 · 2019: 17 · 2018: 19 · 2017: 11 · 2016: 11 · 2015: 17 · 2014: 7 · 2013: 3
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- miR-142-3p, colon cancer, tumor suppressor microRNA, CD133, ABCG2, Lgr5, Oct4, promoter hypomethylation, 3' untranslated region, cyclin D1, G1 cell cycle arrest, 5-fluorouracil sensitivity, cancer stem cells, tumor growth
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily G, Member 2, AC133 Antigen, Animals, Antimetabolites, Antineoplastic, Colonic Neoplasms, Female, Fluorouracil, Glycoproteins, Humans, Male, Neoplasm Proteins, Peptides, Antigens, CD, Apoptosis, ATP-Binding Cassette Transporters, Xenograft Model Antitumor Assays, MicroRNAs, Receptors, G-Protein-Coupled, Cell Line, Tumor, Tumor Burden, Octamer Transcription Factor-3, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells. https://app.cochat.ai/papers/10.1007/s00109-013-1037-x
- The paper
- Shen, W.-W., Zeng, Z., Zhu, W.-X., & Fu, G.-H. (2013). MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-013-1037-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.